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Papillary thyroid cancer (PTC) represents 80–85% of thyroid cancer and its prevalence
has been rising in the last decades. Primary thyroid lymphoma (PTL) accounts for 3% of
extranodal lymphomas and about 5% of thyroid malignancies, having a prevalence of one
or two cases per million people. Mucosa-Associated Lymphoid Tissue lymphoma rep-
resents approximately 30% of PTL. Both entities have an indolent course and a very good
prognosis. Diagnosis is made by ultrasound and ﬁne needle aspiration (FNA) or surgery
specimen pathology. They have also been associated with HT, but pathogenesis and its
links remains to be known. Treatment remains controversial and surgery is generally
accepted in cases of disease limited to thyroid, as the present. Patients with thyroid
nodules should be observed and followed. If there is an enlargement by ultrasound or
clinical symptoms, FNA should be performed promptly. Patients with Hashimoto's
thyroiditis (HT) deserve additional surveillance, since this condition is associated with
both PTC and PTL. In this case, the management with surgery and radioactive iodine
ablation therapy was effective for both entities. Patients with thyroid nodules should be
properly evaluated with ultrasound and thyroid function tests. If there is an enlargement
of the neck, reported by symptoms or ultrasound, it requires further investigation. HT is
associated to both PTC and PTL so if the enlargement of the nodules is on this context
additional tests such as FNA should be performed. In this case, the patient was managed
with surgery and radioactive iodine ablation therapy and it was effective for both entities.1. Introduction
Thyroid cancer represents 1% of all cancer cases in the
United States and it's the most common endocrine malignancy.
Papillary thyroid cancer (PTC) represents the most frequent
variation at countries with iodine sufﬁcient diet [1] and its
prevalence has been rising in the last decades, being about
80–85% [1,2]. More common in women (2.4:1), it has a peakbetween third and ﬁfth decades of life [1]. Also, there are
exogenous factors: radiation exposure, high-iodine diet, ni-
trates, western style life and endogenous factors high levels of
thyroid stimulating hormone, Hashimoto's thyroiditis (HT) and
obesity, associated with PTC [3].
Primary thyroid lymphoma (PTL) accounts for 3% of
extranodal lymphomas and about 5% of thyroid malignancies,
having a prevalence of one to two cases per million people [4,5].
More common in women (3:1) at seventh decade of life, it
develops 5–10 years earlier in men [4]. Its pathogenesis is
unknown, but PTL, autoimmune diseases and antigen
stimulation have been associated. Patients with HT have 40–
80 times more risk, however only 0, 6% develop it [6,7]. It has
been proposed that lymphoid tissue develops in the thyroid in
a context of a long standing HT into a Mucosa-Associated
Lymphoid Tissue (MALT) lymphoma [4].s article under the CC BY-NC-ND license (http://
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A 54-year-old man followed-up due to a goiter enlargement
in last nine months, now presents with associated cervical pain,
dysphonia and dysphagia to solids. The patient is a former
smoker, denies exposition to other toxic agents. He does not
have family history of thyroid cancer. His father died of gastric
cancer and one son has hypothyroidism. On physical examina-
tion, thyroid gland was enlarged asymmetrically. The left lobe
was larger than the right and it had a nodule of 4 cm, soft,
delimited, not adhered to deep tissue and motile at deglutition. A
nodule of 2 cm with the same characteristics was found at right
lobe. There was no palpable cervical lymphadenopathy and the
rest of the examination and laboratory results were unremark-
able. The patient was euthyroid and he didn't take any
medication.
Thyroid ultrasonography found a heterogeneous thyroid
gland with hypoechoic nodules, one of 36 mm × 22 mm at
inferior pole, another nodule of 8 mm at the middle third of left
lobe and three nodules of 9 mm, 7 mm and 4 mm at the right
lobe. Total thyroidectomy was programmed and performed,
without complications. No lymph nodes were removed.
Histopathology found a papillary thyroid microcarcinoma,
classic variant, of 5 mm × 3.5 mm (Figure 1A). The main pa-
renchyma showed a low grade lymphoproliferative process, with
presence of lymphoid follicles and epithelial complexes at thy-
roid follicles. It was classiﬁed as an extranodal marginal zone B-
cell lymphoma of MALT type with compromise of the entire
gland (Figure 1B). Immunohistochemistry studies revealedFigure 1. The pathological assessment.
A, Papillary thyroid microcarcinoma (H&E stain, 100× magniﬁcation); B, Extra
the entire gland, tumor cells are strongly positive to CD20 (Immunohistochemis
epithelium (lymphoepithelial complexes). Remains of thyroid follicles are posipositivity to CD20 (Figure1C), CD79a and cytokeratin
(Figure 1D) and negativity to CD3, CD10, BCL6 and thyro-
globulin. Proliferation rate (Ki67) was 15–20%. The remaining
thyroid parenchyma revealed remains of HT.
The patient was discharged home and prescribed levothyr-
oxine 100 mcg. Two months later surveillance tests were per-
formed, consisting of upper endoscopy, computed tomography
of neck, thorax, abdomen and pelvis, bone scintigraphy and
bone marrow biopsy. They didn't show any evidence of disease.
Two months later the patient had ablation therapy with 80mCi of
I131 after withdrawal from thyroid hormone. There was no evi-
dence of disease on his last visit.
3. Discussion
The coexistence of MALT lymphoma and PTC in a context
of HT is extremely uncommon, with few cases reported [8–10].
Clinical presentation of these cases is variable. The course can
be indolent and only detected by thyroid ultrasound, as the
experiences of Cheng et al [10] and Vassilatou et al [11] or,
more typical of PTL, an enlargement of a neck mass [6] that
can be with obstructive symptoms as hoarseness [8],
dysphonia, neck pain and dysphagia as the present patient or
even severe airway obstruction leading to emergency surgery
[12], or without them, an isolated enlargement [9].
The diagnosis of these entities can be achieved with thyroid
ultrasound and ﬁne needle aspiration (FNA), thyroid biopsy or
after thyroidectomy. Thyroid laboratory workup can result in
euthyroid without medication [8,9,12] as this patient, subclinicalnodal marginal zone B-cell lymphoma of MALT type with compromise of
try CD20, 400× magniﬁcation); C and D, Tumor lymphocytes invading the
tive to cytokeratin (Immunohistochemistry Pan CK, 400× magniﬁcation).
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Therapeutic approach in cases like this requires prioritizing the
most aggressive disease, determined by staging. The other
similar cases were managed with surgery alone [8,12] or with
adjuvant radioactive iodine treatment [9–11] as this patient.
PTC is the most frequent thyroid cancer and it's managed
with surgery and radioactive iodine, therapy is curative often.
Generally, it doesn't metastases out of the neck (5–7%) and is
rare as a cause of death. The following workup includes full
body scan, neck ultrasound, levels of thyroglobulin and anti-
thyroglobulin antibodies [1,2,13].
A fast growing goiter should make suspect of PTL and even
more if there are associated cervical lymphadenopathies. FNA
sample should be used for cytology, ﬂow cytometry and
immunohistochemistry to determine the type because it changes
the management and prognosis [6].
Diffuse large B-cell lymphoma represents nearly 70% of PTL
and has a more aggressive course. Its treatment consists of
combined schemes of rituximab, chemotherapy and radio-
therapy; the disease free survival is almost 75% at 5 years, while
MALT lymphoma has a better prognosis, with a disease free
survival of near 96% at 5 years and its treated with surgery and
radiotherapy either alone or in combination. Radiotherapy alone
has a success of 70–100%, while thyroidectomy is risky, has not
demonstrated to increase overall survival and is reserved for
cases with obstructive impairment [4].
The mechanism that may associate HT with these two entities
is yet to be determined. Nevertheless, the autoimmune process
and antigen exposure seem to have an important role in the
pathogenesis [4]. Total thyroidectomy represented an effective
measure at experience of Cheng et al [10] and Melo et al [9],
with six years and two years without recurrence respectively
[12]. There is not information about long term effects so
appropriate surveillance must be done. This report adds
information about the coexistence of these entities and the
experience we had with its management. Also, we remark that
thyroid nodules must be observed and followed, granting a
FNA if there are clinical symptoms or enlargement at the
neck. Patients with HT in the context of the enlargement of
the goiter by symptoms or ultrasound, deserve additional
surveillance because that condition is associated with both
PTL and PTC.
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